338 related articles for article (PubMed ID: 19389499)
1. Role of allogeneic stem cell transplantation in multiple myeloma.
Bruno B; Giaccone L; Sorasio R; Boccadoro M
Semin Hematol; 2009 Apr; 46(2):158-65. PubMed ID: 19389499
[TBL] [Abstract][Full Text] [Related]
2. Role of allogeneic stem cell transplantation in multiple myeloma.
Thomson KJ; Peggs KS
Expert Rev Anticancer Ther; 2005 Jun; 5(3):455-64. PubMed ID: 16001953
[TBL] [Abstract][Full Text] [Related]
3. Role of stem cell transplantation.
Harousseau JL
Hematol Oncol Clin North Am; 2007 Dec; 21(6):1157-74, x. PubMed ID: 17996593
[TBL] [Abstract][Full Text] [Related]
4. The allogeneic dilemma.
Harousseau JL
Bone Marrow Transplant; 2007 Dec; 40(12):1123-8. PubMed ID: 17680016
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcomes following myeloablative allogeneic transplantation for multiple myeloma compared to autologous transplantation and the impact of graft-versus-myeloma effect.
Khaled Y; Mellacheruvu S; Reddy P; Peres E; Mineishi S
Bone Marrow Transplant; 2009 Sep; 44(5):325-6. PubMed ID: 19204708
[No Abstract] [Full Text] [Related]
6. [Multiple myeloma relapsed or progressed as plasmacytoma after allogeneic reduced-intensity stem cell transplantation: report of three cases].
Sugimoto Y; Nishii K; Miyata E; Fujieda A; Yamaguchi M; Masuya M; Katayama N
Rinsho Ketsueki; 2009 Apr; 50(4):289-94. PubMed ID: 19404022
[TBL] [Abstract][Full Text] [Related]
7. Mini-Midi-Maxi? How to harness the graft-versus-myeloma effect and target molecular remission after allogeneic stem cell transplantation.
Kröger N
Leukemia; 2007 Sep; 21(9):1851-8. PubMed ID: 17568819
[TBL] [Abstract][Full Text] [Related]
8. Autologous transplantation in elderly patients with multiple myeloma: are we asking the right questions?
Klepin HD; Hurd DD
Bone Marrow Transplant; 2006 Nov; 38(9):585-92. PubMed ID: 16953209
[TBL] [Abstract][Full Text] [Related]
9. Allogeneic haematopoietic cell transplantation for multiple myeloma: reducing transplant-related mortality while harnessing the graft-versus-myeloma effect.
Zeiser R; Finke J
Eur J Cancer; 2006 Jul; 42(11):1601-11. PubMed ID: 16759847
[TBL] [Abstract][Full Text] [Related]
10. Evolving transplant options for multiple myeloma: autologous and nonmyeloablative allogenic.
Gibson J; Ho PJ; Joshua D
Transplant Proc; 2004 Oct; 36(8):2501-3. PubMed ID: 15561295
[TBL] [Abstract][Full Text] [Related]
11. Clonal cytogenetic changes and myeloma relapse after reduced intensity conditioning allogeneic transplantation.
Lee CK; Zangari M; Fassas A; Thertulien R; Talamo G; Badros A; Cottler-Fox M; van Rhee F; Barlogie B; Tricot G
Bone Marrow Transplant; 2006 Mar; 37(5):511-5. PubMed ID: 16435020
[TBL] [Abstract][Full Text] [Related]
12. Stem cell transplantation for multiple myeloma: current status and future directions.
Caldera H; Giralt S
Curr Hematol Rep; 2004 Jul; 3(4):249-56. PubMed ID: 15217554
[TBL] [Abstract][Full Text] [Related]
13. Clinical and molecular remission following reduced intensity conditioning and allogeneic transplantation in a patient with refractory multiple myeloma.
Dodero A; Perfetti V; Ciceri F; Corradini P
Haematologica; 2002 Dec; 87(12):ECR41. PubMed ID: 12495912
[No Abstract] [Full Text] [Related]
14. Clinical impact of human Jurkat T-cell-line-derived antithymocyte globulin in multiple myeloma patients undergoing allogeneic stem cell transplantation.
Ayuk F; Perez-Simon JA; Shimoni A; Sureda A; Zabelina T; Schwerdtfeger R; Martino R; Sayer HG; Alegre A; Lahuerta JJ; Atanackovic D; Wolschke C; Nagler A; Zander AR; San Miguel JF; Kröger N
Haematologica; 2008 Sep; 93(9):1343-50. PubMed ID: 18641030
[TBL] [Abstract][Full Text] [Related]
15. Autografting followed by a reduced-intensity conditioning unrelated donor cord blood transplantation for a patient with refractory multiple myeloma: successful engraftment with minimal toxicity.
Ando T; Yujiri T; Tominaga T; Shinya S; Takahashi T; Nomiyama J; Seguchi M; Matsubara A; Fujii Y; Tanizawa Y
Eur J Haematol; 2005 Feb; 74(2):175-9. PubMed ID: 15654912
[TBL] [Abstract][Full Text] [Related]
16. Stem-cell transplantation in multiple myeloma.
Harousseau JL; Moreau P; Attal M; Facon T; Avet-Loiseau H
Best Pract Res Clin Haematol; 2005; 18(4):603-18. PubMed ID: 16026740
[TBL] [Abstract][Full Text] [Related]
17. Early recurrence of rheumatoid arthritis after nonmyeloablative allogeneic blood stem cell transplantation in a patient with multiple myeloma.
Tapprich C; Fenk R; Schneider P; Bernhardt A; Haas R; Kobbe G
Bone Marrow Transplant; 2003 Sep; 32(6):629-31. PubMed ID: 12953137
[TBL] [Abstract][Full Text] [Related]
18. Thrombotic microangiopathy after combined autografting-allografting for multiple myeloma - report of three cases.
Kornacker M; Luft T; Ho AD; Schaefer HJ
Eur J Haematol; 2005 Mar; 74(3):250-3. PubMed ID: 15693795
[TBL] [Abstract][Full Text] [Related]
19. Allogeneic stem cell transplantation for multiple myeloma.
Bensinger W
Hematol Oncol Clin North Am; 2014 Oct; 28(5):891-902. PubMed ID: 25212888
[TBL] [Abstract][Full Text] [Related]
20. Hematopoietic stem cell transplantation in multiple myeloma.
Pant S; Copelan EA
Biol Blood Marrow Transplant; 2007 Aug; 13(8):877-85. PubMed ID: 17640590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
